Replidyne Alternatives & Competitors
12 companies similar to Replidyne — Developing groundbreaking anti-infective products through proprietary DNA replic...
Companies similar to Replidyne
QRxPharma
Pioneering pain management with innovative products and advanced abuse prevention technolo...
DevsHealth
At DevsHealth, we leverage our advanced DeepTech platform to enhance the development of an...
Spectrum Pharmaceuticals
Innovative solutions driving advancements in cancer treatment through strategic developmen...
EOC Pharma Group
Empowering cancer care in China through a robust network of global partnerships, innovativ...
Rival Readout
Competing with Replidyne? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Eton Pharmaceuticals
Rare diseases call for a rare company.
OnQuality Pharmaceuticals Ltd.
developing innovative drugs and drug delivery systems that improve the quality of life of...
AFFIRMA BIOTECH SL
Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant an...
AGY Therapeutics
Pioneering breakthrough treatments for central nervous system diseases through innovative...
IXALTIS SA
DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Nevakar Inc.
Repositioning Drugs for a Better Outcome®
LB Pharmaceuticals, Inc.
Pioneering advancements in CNS treatment by bringing overseas innovations to the U.S. mark...
About Replidyne
Replidyne is a pharmaceutical company specializing in the development and commercialization of innovative anti-infective products. The company, founded in 2000, is focused on developing groundbreaking anti-infective products through proprietary DNA replication technology and strategic in-licensing efforts. Their develo...
Pharmaceutical Company, Anti-infective Products, Innovation, DNA Replication Technology, Specialty Pharmaceuticals, Proprietary Technology, Development Pipeline, In-licensing, Commercialization, Drug Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Replidyne: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Replidyne on 18 Jul 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.